Try
Inspire Medical Systems, Inc.
INSPUnited States
68 filed reports · 405 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
68 reports · Mar 2018 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 190 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Current · 8-KSEC EDGAR | 34 | 182 | Jun 2018 to Jun 2026 |
| Quarterly · 10-QSEC EDGAR | 26 | 3,939 | Mar 2018 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 8 | 3,261 | Dec 2018 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 8-K | Jun 30, 2026 | Aug 3, 2026 | 14 | Open |
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 3, 2026 | 329 | Open |
| FY2026 Q1 | 8-K | Mar 31, 2026 | May 4, 2026 | 12 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 4, 2026 | 186 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 13, 2026 | 862 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Feb 11, 2026 | 12 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Jan 12, 2026 | 2 | Open |
| FY2025 Q3 | 8-K | Sep 30, 2025 | Nov 3, 2025 | 6 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 3, 2025 | 264 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 4, 2025 | 164 | Open |
| FY2025 Q2 | 8-K | Jun 30, 2025 | Aug 4, 2025 | 8 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 5, 2025 | 163 | Open |
Financial data
405 concepts · 7,382 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial383 concepts · 6,951 facts · Jun 2014 to Jul 2026
- Cash and cash equivalents at carrying value49 · Dec 2016 to Jun 2026
- Comprehensive income net of tax48 · Dec 2016 to Jun 2026
- Depreciation depletion and amortization48 · Dec 2016 to Jun 2026
- Gross profit (US GAAP)48 · Dec 2016 to Jun 2026
- Increase decrease in accounts payable48 · Dec 2016 to Jun 2026
- Increase decrease in inventories48 · Dec 2016 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets48 · Dec 2016 to Jun 2026
- Increase decrease in receivables48 · Dec 2016 to Jun 2026
- Net cash provided by used in financing activities48 · Dec 2016 to Jun 2026
- Net cash provided by used in investing activities48 · Dec 2016 to Jun 2026
- Net cash provided by used in operating activities48 · Dec 2016 to Jun 2026
- Net income loss48 · Dec 2016 to Jun 2026
- Operating income loss48 · Dec 2016 to Jun 2026
- Other nonoperating income expense48 · Dec 2016 to Jun 2026
- Payments to acquire property plant and equipment48 · Dec 2016 to Jun 2026
- Proceeds from stock options exercised48 · Dec 2016 to Jun 2026
- Research and development expense48 · Dec 2016 to Jun 2026
- Revenue48 · Dec 2016 to Jun 2026
- Share based compensation48 · Dec 2016 to Jun 2026
- Depreciation and amortization47 · Dec 2016 to Jun 2026
- Income tax expense benefit46 · Dec 2016 to Jun 2026
- Stockholders equity (US GAAP)46 · Dec 2016 to Jun 2026
- Advertising expense45 · Dec 2016 to Dec 2025
- Cash cash equivalents restricted cash and restricted cash equivalents45 · Dec 2016 to Jun 2026
Guidance10 concepts · 182 facts · Aug 2018 to Aug 2026
- Revenue Guidance70 · Aug 2018 to Aug 2026
- Gross Margin Guidance48 · May 2019 to Nov 2025
- Revenue Growth Guidance22 · Aug 2018 to May 2026
- EPS (Diluted) Guidance20 · May 2024 to Aug 2026
- Capital Expenditures Guidance6 · Feb 2026 to Aug 2026
- Effective Tax Rate Guidance6 · Feb 2026 to Aug 2026
- Operating Margin Guidance4 · Feb 2026 to May 2026
- Effective Tax Rate Guidance (Adjusted (non-GAAP))2 · Aug 2026
- EPS (Diluted) Guidance (Adjusted (non-GAAP))2 · Aug 2026
- Operating Margin Guidance (Adjusted (non-GAAP))2 · Aug 2026
Segment9 concepts · 126 facts · Dec 2022 to Jun 2026
- Advertising expense14 · Dec 2022 to Jun 2026
- Cost of goods and services sold (US GAAP)14 · Dec 2022 to Jun 2026
- Income tax expense benefit14 · Dec 2022 to Jun 2026
- Net income loss14 · Dec 2022 to Jun 2026
- Nonoperating income expense14 · Dec 2022 to Jun 2026
- Operating income loss14 · Dec 2022 to Jun 2026
- Operating Segment14 · Dec 2022 to Jun 2026
- Research and development expense14 · Dec 2022 to Jun 2026
- Revenue14 · Dec 2022 to Jun 2026
Geography2 concepts · 115 facts · Dec 2016 to Jun 2026
- Revenue106 · Dec 2016 to Jun 2026
- Property, Plant & Equipment, Net9 · Dec 2023 to Jun 2024
Product1 concepts · 8 facts · Jun 2022 to Dec 2023
- Research and development expense8 · Jun 2022 to Dec 2023
Segments
249 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments1 member · 126 facts
- Operating126 · Dec 2022 to Jun 2026
Statement geographicalsrt:StatementGeographicalAxis7 members · 107 facts
- US46 · Dec 2016 to Jun 2026
- Non Us25 · Mar 2021 to Jun 2026
- Europe22 · Dec 2016 to Sep 2021
- All Other Countries5 · Dec 2019 to Dec 2023
- Us4 · Dec 2023 to Jun 2024
- All other countries3 · Dec 2023 to Mar 2024
- Non us2 · Dec 2023 to Jun 2024
Product or service1 member · 8 facts
- Regulatory Pre Launch Of Product Inventory8 · Jun 2022 to Dec 2023
Statement geographicalus-gaap:StatementGeographicalAxis2 members · 8 facts
- Europe4 · Mar 2017 to Jun 2018
- US4 · Mar 2017 to Jun 2018
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
1 calls · Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 3, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 17, 2026) and refreshed every few hours.